Work Type
Publication
Journal
Clinical and Translational Science
Volume
11
Issue
1
Inclusive Pages
77-84
Publication Date
2018
Language
English
Document Type
Article
Link to Published Version
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5759746/
Recommended Citation
Luke DA, Sarli CC, Suiter AM, Carothers BJ, Combs TB, Allen JL, Beers CE, Evanoff BA.The Translational Science Benefits Model: A New Framework for Assessing the Health and Societal Benefits of Clinical and Translational Sciences. Clin Transl Sci. 2018 Jan;11(1):77-84. doi: 10.1111/cts.12495. Epub 2017 Sep 8. https://www.ncbi.nlm.nih.gov/pubmed/28887873
COinS
Description
We report the development of the Translational Science Benefits Model (TSBM), a framework designed to support institutional assessment of clinical and translational research outcomes to measure clinical and community health impacts beyond bibliometric measures. The TSBM includes 30 specific and potentially measurable indicators that reflect benefits that accrue from clinical and translational science research such as products, system characteristics, or activities. Development of the TSBM was based on literature review, a modified Delphi method, and in‐house expert panel feedback. Three case studies illustrate the feasibility and face validity of the TSBM for identification of clinical and community health impacts that result from translational science activities. Future plans for the TSBM include further pilot testing and a resource library that will be freely available for evaluators, translational scientists, and academic institutions who wish to implement the TSBM framework in their own evaluation efforts.